Enveric Biosciences, Inc. — Director's Dealing 2017

Nov 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2017-11-17

Reporting Person: Devanur Giri (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-17	Common Stock	P	12121	$4.115	Acquired	2191346	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-17	Warrant (Right to Buy)	$4.115	P	12121	Acquired	2022-11-21	Common Stock (12121)	Direct

Footnotes

F1: The warrant gives the Reporting Person the right to purchase up to 12,121 shares of common stock at an exercise price equal to $4.115 per share. The warrant will expire on November 21, 2022.